abstract |
The present invention relates to the field of recombinant protein production and vaccine production. In particular, the present invention provides means and methods for preparing CMV oligosaccharides gH / gL / UL128 / UL130 / UL131A complexes. More specifically, the present invention provides a CMV oligomeric g / g / UL128 / UL130 / UL131A complex produced in a baculovirus system, which can be used as a vaccine against CMV. |